$56.30 -0.51 (%) Mylan Inc - NASDAQ

Jan. 27, 2015 | 04:00 PM

Partner Headlines

  1. Big Cap Stocks Mylan, American Tower Near Buy Points

    IBD | Jan. 26, 2015 | 18:42PM EST
  2. Mylan Labs expanded

    IBD | Jan. 26, 2015 | 18:40PM EST
  3. Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent

    Benzinga | Jan. 26, 2015 | 10:59AM EST
  4. Cramer Weighs In On Transocean LTD, Mylan Inc And Honda Motor Co Ltd

    Benzinga | Jan. 25, 2015 | 14:42PM EST
  5. Teva Pharmaceutical

    IBD | Jan. 20, 2015 | 18:45PM EST
  6. Feeling Good With This Med Company

    GuruFocus | Jan. 20, 2015 | 15:12PM EST
  7. 3 Reasons To Be Bullish On Generic Drug Firm Akorn

    IBD | Jan. 15, 2015 | 14:12PM EST
  8. Mylan Launches Generic Diovan® Tablets

    Benzinga | Jan. 5, 2015 | 13:01PM EST
  9. Will 2015 Be Different For Big Cap Stocks?

    IBD | Dec. 29, 2014 | 17:27PM EST
  10. Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

    Benzinga | Dec. 18, 2014 | 04:31AM EST
  11. Teva Upgraded On Strength Of Copaxone MS Drug

    IBD | Dec. 12, 2014 | 10:38AM EST
  12. Mylan Launches First Generic Version Of Orapred ODT

    Benzinga | Dec. 11, 2014 | 07:04AM EST
  13. Merck-Cubist Deal Going Ahead Despite Patent Setback

    IBD | Dec. 9, 2014 | 11:27AM EST
  14. Two Gauges That Point To Fund Buying In A Stock

    IBD | Dec. 8, 2014 | 18:18PM EST
  15. Great Stocks In 2014: Airline, Video Game, Drugs Lead

    IBD | Dec. 4, 2014 | 18:53PM EST
  16. Medical Issues Keep Climbing Into Sell Zone

    IBD | Dec. 4, 2014 | 18:20PM EST
  17. Mylan Receives Tentative FDA Approval For Pediatric Formulations Of Abacavir/Lamivudine Through Innovative Collaboration With ViiV Healthcare And Clinton Health Access Initiative

    Benzinga | Dec. 4, 2014 | 10:01AM EST
  18. Weekly CFO Sells Highlight: Hospira Inc, Rockwood Holdings Inc, Mylan Inc.

    GuruFocus | Nov. 30, 2014 | 13:58PM EST
  19. CNBC's Stock Pops & Drops From November 26

    Benzinga | Nov. 28, 2014 | 07:01AM EST
  20. Stocks Mixed In Weak Volume; Mylan, Hain At New Highs

    IBD | Nov. 26, 2014 | 13:19PM EST
  21. Five Ethical Drugmakers Keep Leadership Positions

    IBD | Nov. 17, 2014 | 18:27PM EST
  22. Big Cap 20 Stuffed With Medical Names

    IBD | Nov. 10, 2014 | 19:34PM EST
  23. Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal

    IBD | Oct. 31, 2014 | 11:17AM EST
  24. Stocks Surge At Starting Bell; Mylan, Expedia, GoPro Rocket

    IBD | Oct. 31, 2014 | 10:36AM EST
  25. MYLAN

    IBD | Oct. 30, 2014 | 19:13PM EST
  26. Earnings Scheduled For October 30, 2014

    Benzinga | Oct. 30, 2014 | 05:12AM EST
  27. Biogen, Thermo Reports Disappoint; Abbott Accelerates

    IBD | Oct. 22, 2014 | 11:18AM EST
  28. Mylan Adjusts Pricing Terms Of Manufacturing Pacts With Abbot

    Benzinga | Oct. 22, 2014 | 07:24AM EST
  29. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  30. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  31. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  32. Bank Of America Raises 2014 Outlook For Mylan Inc

    Benzinga | Oct. 6, 2014 | 07:22AM EST
  33. Mylan

    IBD | Oct. 3, 2014 | 18:44PM EST
  34. Jazz Pharmaceuticals Uses New Cash To Buy For Growth

    IBD | Oct. 3, 2014 | 14:39PM EST
  35. Stocks Open Higher On Jobs Data; Mylan, Salix, Mobileye Climb

    IBD | Oct. 3, 2014 | 10:39AM EST
  36. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 3, 2014 | 08:44AM EST
  37. Inversion Crackdown Leaves Several Deals In Limbo

    Benzinga | Sep. 23, 2014 | 12:41PM EST
  38. Gilead to license Sovaldi

    IBD | Sep. 15, 2014 | 18:53PM EST
  39. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  40. US Stock Futures Down Ahead Of Industrial Production Report

    Benzinga | Sep. 15, 2014 | 07:13AM EST
  41. Mylan In Pact With Gilead To Accelerate Access To Hepatitis C

    Benzinga | Sep. 15, 2014 | 06:31AM EST
  42. Corporate Tax Cuts Would Help Treasury And Investors

    IBD | Sep. 11, 2014 | 18:04PM EST
  43. Mylan to Acquire U.S. Rights to Arixtra Injection From Aspen

    Benzinga | Sep. 10, 2014 | 07:02AM EST
  44. Court Grants Summary Judgment In Favor Of Mylan And FDA Related To Generic

    Benzinga | Sep. 8, 2014 | 07:02AM EST
  45. Why Burger King Isn't Like Walgreen In Tax Inversions

    IBD | Aug. 25, 2014 | 13:23PM EST
  46. Benzinga's Top Downgrades

    Benzinga | Aug. 8, 2014 | 09:04AM EST
  47. US Stock Futures Edge Higher Ahead Of Productivity Data

    Benzinga | Aug. 8, 2014 | 07:41AM EST
  48. RBC Capital Downgrades Mylan To Sector Perform

    Benzinga | Aug. 8, 2014 | 07:10AM EST
  49. Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide

    IBD | Aug. 7, 2014 | 18:50PM EST
  50. Mylan shares down on Q2 miss

    IBD | Aug. 7, 2014 | 18:41PM EST
Trading Center